Search results
Navigating Alzheimer's care: The promises and limits of a new drug
KPBS San Diego· 1 day agoAlzheimer's Disease and related dementias take a heavy toll on individuals and their caregivers. New...
TIME100 Health: David Ricks
Time via AOL· 13 hours agoRicks is waiting for a decision from the FDA about its Alzheimer’s drug donanemab, a call the agency delayed this ...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 16 hours agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002...Motley Fool recommends Novo Nordisk. The Motley Fool has a...
FDA Issues Much-Anticipated Final Rule on Laboratory Developed Tests | JD Supra
JD Supra· 19 hours agoThe FDA will phase out its policy of LDT enforcement discretion over the next four years in five stages, transitioning to active oversight of LDTs. The U.S
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
Waterloo-Cedar Falls Courier· 3 days agoThe regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar ...
To save lives, the FDA must change how it evaluates rare disease treatments
Salon.com· 2 days agoFor some conditions, few approved treatments exist. Without accelerated approval, theFDA is failing...
FDA moves to regulate some tests it says may be unreliable
Anchorage Daily News· 3 days agoThe Food and Drug Administration has finalized a divisive plan to regulate laboratory medical tests...
Baptist Health offering new infusion treatment for those in early stages of Alzheimer's
KATV Little Rock· 3 days agoIn a 18-month long study, intravenous (IV) infusion treatment with LEQEMBI (Lecanemab) was proven to slow the progress of early Alzheimer's disease. People ...
Forget Nvidia, These Unstoppable Stocks Are Better Buys
Motley Fool via Yahoo Finance· 5 days agoIts recent earnings numbers...Advisor provides investors with an easy-to-follow blueprint for...